Attention deficit hyperactivity disorder

Daniel Wilson, Jawed Muhammad, William Marcil, Fred Petty

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Attention Deficit Hyperactivity Disorder (ADHD) is a generalized impulsivity disorder that manifests itself at the motor, emotional, social, and attention levels. It was first documented in 1902 by British pediatrician George Still when he described a group of 20 children with hyperactivity and impulsive behavior. It has in the past been termed "Minimal Brain Dysfunction", "Minimal Brain Damage", and "Hyperkinetic Behavior Disorder" ....

Original languageEnglish
Title of host publicationxPharm: The Comprehensive Pharmacology Reference
PublisherElsevier Inc.
Pages1-4
Number of pages4
ISBN (Print)9780080552323
DOIs
StatePublished - 2011

Fingerprint

Impulsive Behavior
Attention Deficit Disorder with Hyperactivity
Mental Disorders
Brain
Pediatricians

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Wilson, D., Muhammad, J., Marcil, W., & Petty, F. (2011). Attention deficit hyperactivity disorder. In xPharm: The Comprehensive Pharmacology Reference (pp. 1-4). Elsevier Inc.. https://doi.org/10.1016/B978-008055232-3.60637-3

Attention deficit hyperactivity disorder. / Wilson, Daniel; Muhammad, Jawed; Marcil, William; Petty, Fred.

xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., 2011. p. 1-4.

Research output: Chapter in Book/Report/Conference proceedingChapter

Wilson, D, Muhammad, J, Marcil, W & Petty, F 2011, Attention deficit hyperactivity disorder. in xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., pp. 1-4. https://doi.org/10.1016/B978-008055232-3.60637-3
Wilson D, Muhammad J, Marcil W, Petty F. Attention deficit hyperactivity disorder. In xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc. 2011. p. 1-4 https://doi.org/10.1016/B978-008055232-3.60637-3
Wilson, Daniel ; Muhammad, Jawed ; Marcil, William ; Petty, Fred. / Attention deficit hyperactivity disorder. xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., 2011. pp. 1-4
@inbook{9bedbdbe5ca84fee947cf47a05f32ded,
title = "Attention deficit hyperactivity disorder",
abstract = "Attention Deficit Hyperactivity Disorder (ADHD) is a generalized impulsivity disorder that manifests itself at the motor, emotional, social, and attention levels. It was first documented in 1902 by British pediatrician George Still when he described a group of 20 children with hyperactivity and impulsive behavior. It has in the past been termed {"}Minimal Brain Dysfunction{"}, {"}Minimal Brain Damage{"}, and {"}Hyperkinetic Behavior Disorder{"} ....",
author = "Daniel Wilson and Jawed Muhammad and William Marcil and Fred Petty",
year = "2011",
doi = "10.1016/B978-008055232-3.60637-3",
language = "English",
isbn = "9780080552323",
pages = "1--4",
booktitle = "xPharm: The Comprehensive Pharmacology Reference",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Attention deficit hyperactivity disorder

AU - Wilson, Daniel

AU - Muhammad, Jawed

AU - Marcil, William

AU - Petty, Fred

PY - 2011

Y1 - 2011

N2 - Attention Deficit Hyperactivity Disorder (ADHD) is a generalized impulsivity disorder that manifests itself at the motor, emotional, social, and attention levels. It was first documented in 1902 by British pediatrician George Still when he described a group of 20 children with hyperactivity and impulsive behavior. It has in the past been termed "Minimal Brain Dysfunction", "Minimal Brain Damage", and "Hyperkinetic Behavior Disorder" ....

AB - Attention Deficit Hyperactivity Disorder (ADHD) is a generalized impulsivity disorder that manifests itself at the motor, emotional, social, and attention levels. It was first documented in 1902 by British pediatrician George Still when he described a group of 20 children with hyperactivity and impulsive behavior. It has in the past been termed "Minimal Brain Dysfunction", "Minimal Brain Damage", and "Hyperkinetic Behavior Disorder" ....

UR - http://www.scopus.com/inward/record.url?scp=84884063387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884063387&partnerID=8YFLogxK

U2 - 10.1016/B978-008055232-3.60637-3

DO - 10.1016/B978-008055232-3.60637-3

M3 - Chapter

SN - 9780080552323

SP - 1

EP - 4

BT - xPharm: The Comprehensive Pharmacology Reference

PB - Elsevier Inc.

ER -